Brief: GammaCore nVNS Selected For Department Of Defense BOOST Program
April 19 (Reuters) - electroCore, Inc. ECOR.O :
* GAMMACORE™ NON-INVASIVE VAGUS NERVE STIMULATION (NVNS)
SELECTED
FOR DEPARTMENT OF DEFENSE BIOTECH OPTIMIZED FOR OPERATIONAL
SOLUTIONS AND TACTICS (BOOST) PROGRAM
* ELECTROCORE - SHOULD BOOST PROGRAM CONFIRM INITIAL
FINDINGS,
PROJECT CALLS FOR CO TO BE PREPARED TO PROVIDE FIELD READY
DEVICES TO USAF IN H2 OF 2023
Source text for Eikon: ID:nGNX4BRlHT
Further company coverage: ECOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on electroCore
See all newselectroCore, Inc. reports results for the quarter ended June 30 - Earnings Summary
electroCore Q2 revenue jumps, but slightly misses estimates
Brief: electroCore Q2 Net Income USD -3.059 Million
electroCore, Inc. expected to post a loss of 42 cents a share - Earnings Preview
electroCore reiterates FY 2026 revenue guidance